Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients
暂无分享,去创建一个
Christina Lioma | Akshay Pai | Bulat Ibragimov | Oswin Krause | Christian Igel | Mads Nielsen | Wouter Boomsma | Martin Lillholm | Jens Petersen | Raghavendra Selvan | Allan Linneberg | Nicki Skafte Detlefsen | Anders Perner | Andreas D. Lauritzen | Jon Middleton | Abraham George Smith | Marleen de Bruijne | C. Igel | M. Nielsen | M. Lillholm | A. Pai | C. Lioma | B. Ibragimov | A. Linneberg | Wouter Boomsma | Raghavendra Selvan | Jens Petersen | A. Perner | M. Ghazi | H. Thorsen-Meyer | S. Lorenzen | E. Jimenez‐Solem | N. Detlefsen | Marie Helleberg | T. Petersen | Espen Jimenez Solem | Oswin Krause | Casper Hansen | C. Hansen | Stephan Lorentzen | J. Petersen | M. Nyeland | M. Ankarfeldt | Gert Mehl Virenfeldt | M. Winther-Jensen | M. Helleberg | B. Kaas-Hansen | Jon Middleton | S. Mogensen | Mikkel Bonde | A. Bonde | M. Sillesen | Martin Sillesen | Benjamin Skov Kaas-Hansen | Tonny Studsgaard Petersen | Casper Worm Hansen | Christian Hansen | Stephan Lorentzen | Janne Petersen | Martin Erik Nyeland | Mikkel Zoellner Ankarfeldt | M. Winther-Jensen | Mostafa Mediphour Ghazi | Andreas Lauritzen | Stine Hasling Mogensen | Hans Christian Thorsen-Meyer | Mikkel Bonde | Alexander Bonde | B. S. Kaas-Hansen | M. Z. Ankarfeldt | E. J. Solem | Hans-Christian Thorsen-Meyer
[1] P. Serruys,et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study , 2020, European heart journal.
[2] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[3] Carson K. Lam,et al. Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trial , 2020, Computers in Biology and Medicine.
[4] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[5] K. Cao,et al. Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT , 2020, Radiology.
[6] G. Heinze,et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal , 2020, BMJ.
[7] J. Soriano,et al. Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing , 2020, Journal of medical Internet research.
[8] Yoon Jung Choi,et al. Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study , 2020, Scientific reports.
[9] Silke Janitza,et al. On the overestimation of random forest’s out-of-bag error , 2018, PloS one.
[10] Ding Ma,et al. Machine learning based early warning system enables accurate mortality risk prediction for COVID-19 , 2020, Nature Communications.
[11] Sven Van Poucke,et al. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies , 2020, Journal of clinical and translational hepatology.
[12] Lei Dong,et al. Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.
[13] J. Shepard,et al. Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury. , 2020, The New England journal of medicine.
[14] D. Mathieu,et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.
[15] J. Legramante,et al. Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2. , 2020, Clinical medicine.
[16] Esmita Charani,et al. Prognostic Modeling of COVID-19 Using Artificial Intelligence in the United Kingdom: Model Development and Validation , 2020, Journal of Medical Internet Research.
[17] J. Montaner,et al. Multisystem organ failure predicts mortality of ICU patients with acute respiratory failure secondary to AIDS-related PCP. , 1992, Chest.
[18] Bing Yu,et al. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID‐19 , 2020, Journal of medical virology.
[19] Tjerk P. Straatsma,et al. NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations , 2010, Comput. Phys. Commun..
[20] Nan Tang,et al. SARS-CoV-2 and viral sepsis: observations and hypotheses , 2020, The Lancet.
[21] Heng Fan,et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19 , 2020, Diabetes/metabolism research and reviews.
[22] Wenhong Zhang,et al. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study , 2020, BMC Medicine.
[23] G. Collins,et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies , 2019, Annals of Internal Medicine.
[24] A. Harky,et al. COVID-19 and Multiorgan Response , 2020, Current Problems in Cardiology.
[25] L. Mombaerts,et al. An interpretable mortality prediction model for COVID-19 patients , 2020, Nature Machine Intelligence.
[26] Iain B McInnes,et al. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. , 2020, Circulation.
[27] F. Cabitza,et al. Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests , 2020, medRxiv.
[28] J. Carcillo,et al. Hyperferritinemia and inflammation , 2017, International immunology.
[29] J. Syrjänen,et al. Obesity and the outcome of infection. , 2010, The Lancet. Infectious diseases.
[30] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.
[31] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[32] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[33] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[34] D. Melzer,et al. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.
[35] Adam Trendowicz,et al. Model Development and Validation , 2013 .
[36] C. Mantzoros,et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York , 2020, Metabolism.
[37] Russ B. Altman,et al. Missing value estimation methods for DNA microarrays , 2001, Bioinform..
[38] Richard D Riley,et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal , 2020 .
[39] Lei Liu,et al. COVID-19: Abnormal liver function tests , 2020, Journal of Hepatology.
[40] S. Petersen,et al. COVID-19 and the UK Biobank—Opportunities and Challenges for Research and Collaboration With Other Large Population Studies , 2020, Frontiers in Cardiovascular Medicine.